John Martin Manser, Dr. Balz Hösly and Dr. Peter Kaemmerer will not be standing for re-election to the Board of Directors at the Shareholders’ Meeting of Helvetia Holding AG. This will allow Helvetia’s Board to be reduced in size as planned, now that the successful integration of Nationale Suisse into Helvetia is largely complete.
Many years of dedicated service
John Martin Manser joined the Board of Directors of the insurance group in 1996 and has chaired the Investment and Risk Committee for the last 19 years. He was also a member of the Nomination and Compensation Committee. He is not standing for re-election for age-related reasons. Dr. Pierin Vincenz, Chairman of the Board of Directors, said: “On behalf of the whole company, I extend my sincerest thanks to John Martin Manser for his many years of dedicated service. With his profound expertise in financial, investment and risk matters he has played a key role in shaping the company over the last 23 years, and in so doing has made a significant contribution to Helvetia’s success.”
Successful merger with Nationale Suisse
Dr. Balz Hösly and Dr. Peter Kaemmerer were elected to Helvetia’s Board of Directors in 2014 following the merger with Nationale Suisse. Both had been members of the Board of Directors of the former Nationale Suisse since 2007 – Dr. Peter Kaemmerer until 2014, and Dr. Balz Hösly until 2015 as he helped oversee the integration of the two companies from the Nationale Suisse side. Dr.Pierin Vincenz stated: “Helvetia owes a great debt of thanks to Dr. Balz Hösly and Dr. Peter Kaemmerer. They have made an invaluable contribution to the successful merger of Helvetia and Nationale Suisse, and to ensuring that the integration process is well on track.”
The Board of Directors of Helvetia Holding AG is proposing to the Ordinary Shareholders’ Meeting on 22April 2016 that Chairman of the Board of Directors Dr.Pierin Vincenz be re-elected, along with the other nine existing members.
This media release is also available on our website